Abstract
In terms of impact on and cost to society psychiatric disorders are among the most important health problems of today. Current estimates from the US suggest that the collective cost of psychiatric diseases could amount to one-third of the total health care budget with a cumulative lifetime prevalence of 30%. While undoubtedly improvements have been made in the diagnosis and treatment of at least the symptoms of mental illness, there has been frustratingly little progress in elucidating the molecular mechanisms. However, a fundamentally different approach to study molecular mechanisms of psychiatric diseases is emerging as a result of technological advances in expression profiling methods. This comprises the investigation of the expressed disease ‘phenotypes’, developing from the differential gene and protein expression in the central nervous system as a result of the complex interaction between genetic predisposition and environmental modulation. This paper will focus on proteomics, expression profiling at the protein level, reviewing some of the available tools and their application in the molecular analysis of psychiatric disease.
Keywords: proteomics, schizophrenia, 2d electrophoresis, psychiatry, expression profiling, image analysis
Current Molecular Medicine
Title: Proteomics in the Discovery of New Therapeutic Targets for Psychiatric Disease
Volume: 3 Issue: 5
Author(s): Hans Voshol, Marc J. Glucksman and Jan van Oostrum
Affiliation:
Keywords: proteomics, schizophrenia, 2d electrophoresis, psychiatry, expression profiling, image analysis
Abstract: In terms of impact on and cost to society psychiatric disorders are among the most important health problems of today. Current estimates from the US suggest that the collective cost of psychiatric diseases could amount to one-third of the total health care budget with a cumulative lifetime prevalence of 30%. While undoubtedly improvements have been made in the diagnosis and treatment of at least the symptoms of mental illness, there has been frustratingly little progress in elucidating the molecular mechanisms. However, a fundamentally different approach to study molecular mechanisms of psychiatric diseases is emerging as a result of technological advances in expression profiling methods. This comprises the investigation of the expressed disease ‘phenotypes’, developing from the differential gene and protein expression in the central nervous system as a result of the complex interaction between genetic predisposition and environmental modulation. This paper will focus on proteomics, expression profiling at the protein level, reviewing some of the available tools and their application in the molecular analysis of psychiatric disease.
Export Options
About this article
Cite this article as:
Voshol Hans, Glucksman J. Marc and Oostrum van Jan, Proteomics in the Discovery of New Therapeutic Targets for Psychiatric Disease, Current Molecular Medicine 2003; 3 (5) . https://dx.doi.org/10.2174/1566524033479645
DOI https://dx.doi.org/10.2174/1566524033479645 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Exosomes and Exosomal microRNAs in Age-associated Stroke
Current Vascular Pharmacology Nanocarriers for Tracking and Treating Diseases
Current Medicinal Chemistry Biomarker Assessment in Nutritional Modulation of Oxidative Stress-Induced Cancer Development by Lipid-Related Bioactive Molecules
Recent Patents on Anti-Cancer Drug Discovery The Proteins Interacting with Prmt5 in Medaka (Oryzias latipes) Identified by Yeast Two-Hybridization
Protein & Peptide Letters Recent Patents in Autophagy and Immune Response
Recent Patents on Inflammation & Allergy Drug Discovery Evolution of Resistance to Cancer Therapy
Current Pharmaceutical Design Prospects for Clinical Introduction of Nitroimidazole Antibiotics for the Treatment of Tuberculosis
Current Pharmaceutical Design Biomedical Applications of Nanomaterials Containing Gadolinium
Current Inorganic Chemistry (Discontinued) Membrane Domains and the “Lipid Raft” Concept
Current Medicinal Chemistry Systemic Sclerosis Associated Interstitial Lung Disease
Current Respiratory Medicine Reviews Advances in the Management of Brain Tumors in Infants
Current Cancer Therapy Reviews Cell Cycle Inhibition in Malignant Lymphoma: Disease Control by Attacking the Cellular Proliferation Machinery
Current Drug Targets Cyclin-Dependent Kinase as a Novel Therapeutic Target: An Endless Story
Current Chemical Biology Liposomes: An Emerging Approach for the Treatment of Cancer
Current Pharmaceutical Design SUBJECT INDEX TO VOLUME 1
Current Pharmaceutical Biotechnology Modulators of Protein-Protein Interactions – Novel Approaches in Targeting Protein Kinases and Other Pharmaceutically Relevant Biomolecules
Current Topics in Medicinal Chemistry Bioinformatics Approach to BDNF and BDNF-Related Disorders
Current Neuropharmacology The Anticancer Properties of Dietary Polyphenols and its Relation with Apoptosis
Current Pharmaceutical Design Macrocyclic Histone Deacetylase Inhibitors
Current Topics in Medicinal Chemistry Bacterial Toxins: Potential Weapons Against HIV Infection
Current Pharmaceutical Design